Hellma UK Ltd

Activities: Analysis

Trending Articles

  1. Thermo Fisher launches next-gen microarray analyser to accelerate pharmacogenomic research The analyser combines four key genotyping processes into a single, integrated device, allowing researchers to cover the widest range of populations for genome-wide association...
  2. UT Austin honours AustinPx for breakthrough drug delivery innovation Fourth industry accolade in the past year recognises breakthrough KinetiSol Technology for advancing pharmaceutical research and innovation
  3. Nanoform collaborates with A.forall and IMGA to outlicence Nanoencorafenib Nanoform will establish a new company, BRAFMed, to progress the clinical development and future outlicensing of the patient-centric nanoformulation of encorafenib
  4. AstraZeneca strikes deal with US government to cut drug prices and boost domestic manufacturing AstraZeneca has reached an agreement with the Trump administration to lower medicine costs, pledging $50bn in US manufacturing and R&D investment, whilst safeguarding the...
  5. Aenova unveils ambitious sustainability strategy for  a more responsible future The initiative focuses on environmental stewardship, social responsibility and good governance, underscoring Aenova’s commitment to building a healthier future for the...

Upcoming event

CPHI Frankfurt 2025

28–30 October 2025 | Exhibition | Frankfurt, Germany See all